ASML's Buyback Discipline Meets a Three-Quarters Exit: Two Forces Pulling the Chip Giant in Opposite Directions

ASML continues its buyback program despite a 15% stock decline, signaling confidence. Institutional exit by AlTi Global appears isolated.

The Dutch lithography powerhouse is quietly doing what it does best: buying back its own stock with mechanical regularity. On Monday, ASML disclosed another tranche of repurchases under its multi-year buyback framework, scooping up shares on every trading day between August 17 and August 21. The daily outlay ranged between roughly €77 million and €79 million, with the company acquiring between 48,280 and 51,815 shares at weighted average prices spanning €1,506.98 to €1,618.13.

The purchases are notable not just for their consistency but for their timing. On August 20, ASML paid a weighted average of €1,506.98 per share — barely above the current trading level of €1,493.40. The stock has shed 8.2 percent over the past seven trading sessions, a slide that has left many investors on edge. Yet the company appears unfazed, continuing to buy whether the price sits at €1,500 or €1,600.

A Steep Decline From the Summer Peak

Monday's close of €1,492.80 marked a 1.0 percent drop on the day and a 4.2 percent decline on the week. The shares now trade roughly 15 percent below their 52-week high of €1,748.00, a level reached during the summer's record-setting run. Despite the pullback, the stock remains up a formidable 62 percent year-to-date — a gain most blue chips could only envy.

The buyback program, which began in late January and has been executed in successive tranches since, is part of a broader 2026–2028 framework that the company has signaled it intends to work through regardless of market conditions. For management, the message embedded in these weekly disclosures is straightforward: they still consider the stock attractively priced, even as sentiment sours around them.

One Investor's Exit, Read in Context

That confidence stands in sharp contrast to the actions of at least one institutional holder. AlTi Global cut its ASML position by 76.3 percent during the second quarter, according to a Form 13F filing with the U.S. Securities and Exchange Commission. The disclosure, which surfaced alongside Monday's buyback report, raises an obvious question: is this the leading edge of a broader institutional retreat, or an isolated portfolio decision?

So far, the evidence points to the latter. No other major position has been reduced on a comparable scale in recent filings. And as analysts are quick to note, 13F filings are backward-looking snapshots — they reflect positioning at the end of a prior quarter and say little about current allocations. Treating them as a trend reversal rather than a point-in-time observation would be a mistake.

The Strategic Case Remains Intact

Bernstein reaffirmed its buy recommendation on ASML on August 10, citing the company's continued leadership in lithography and its roadmap for higher machine throughput rates. That endorsement, now two weeks old, speaks to a broader point: the recent weakness looks more like a market reaction to global risk factors than a verdict on the company's business model.

ASML occupies a singular position in the semiconductor supply chain. Its lithography systems are the bottleneck through which all modern chip production must pass — no EUV technology, no advanced processor manufacturing. That structural indispensability is precisely why portfolio reshuffling by individual fund houses says little about the company's strategic substance.

A Counterweight to Nervousness

The buyback program, for all its routine appearance, functions as a quiet counterweight to the volatility that has gripped the stock. By continuously withdrawing shares from the market, ASML provides a floor of sorts beneath its own valuation — a mechanism that gains importance precisely when investor anxiety runs high.

The real test comes on October 14, when ASML is scheduled to report its next quarterly results. Until then, the repurchase program will likely continue its unglamorous work, showing up not in headlines but in weekly regulatory notices. For investors trying to see the forest through the trees, that steady, unspectacular discipline may be the most telling signal of all.